Skip to main content
Figure 9 | BMC Cancer

Figure 9

From: Cellular responses of BRCA1-defective and triple-negative breast cancer cells and in vitro BRCA1 interactions induced by metallo-intercalator ruthenium(II) complexes containing chloro-substituted phenylazopyridine

Figure 9

mRNA determination. MCF-7 (A), MDA-MB-231 (B), and HCC1937 (C) cells were treated with appropriate IC50 concentrations of 1 or 2 (Table 1) for 24 h. The transcript abundance of the genes was assessed by a real-time quantitative RT-PCR, normalized with the expression of β-Actin and relative to the expression of untreated control cells. Data were analyzed according to the 2-∆∆C T method [27]. All experiments were performed in triplicate.

Back to article page